SOST and osteogenesis imperfecta: Aptscl56 promoted bone formation in OI mice via targeting sclerostin loop3. In our in vitro genetic truncation studies, loop3 was demonstrated to be critical for sclerostin's antagonistic effect on Wnt signaling pathway and osteogenic potential in primary osteoblasts isolated from Col1a2+/G610C mice.